Yanlan Chai1, Juan Wang1, Tao Wang1, Yunyi Yang1, Jin Su1, Fan Shi1, Jiquan Wang1, Xi Zhou2, Bin He1, Hailin Ma1, Zi Liu3. 1. Department of Radiotherapy Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, PR China. 2. Department of Radiotherapy Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, PR China; Renmin Hospital, Hubei University of Medicine, PR China. 3. Department of Radiotherapy Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, PR China. Electronic address: liuzmail@163.com.
Abstract
OBJECTIVE: Radiation-induced acute intestinal symptoms (RIAISs) are a common complication of radiotherapy for cervical cancer. The aim of this study was to use (1)H nuclear magnetic resonance ((1)H NMR) combined with chemometric analysis to develop a metabolic profile of patients with RIAISs. METHODS: Fecal samples were collected from 66 patients with cervical cancer before and after pelvic radiotherapy. After radiotherapy, RIAISs occurred in eleven patients. We selected another 11 patients from participants without RIAISs whose age, stage, histological type and treatment methods are matched with RIAIS patients as the control group. (1)H NMR spectroscopy combined with multivariate pattern recognition analysis was used to generate metabolic profile data, as well as to establish a RIAIS-specific metabolic phenotype. RESULTS: Orthogonal partial least-squares discriminant analysis was used to distinguish samples between the pre- and post-radiotherapy RIAIS patients and between RIAIS patients and controls. Fecal samples from RIAIS patients after pelvic radiotherapy were characterized by increased concentrations of α-ketobutyrate, valine, uracil, tyrosine, trimethylamine N-oxide, phenylalanine, lysine, isoleucine, glutamine, creatinine, creatine, bile acids, aminohippurate, and alanine, accompanied by reduced concentrations of α-glucose, n-butyrate, methylamine, and ethanol relative to samples from RIAIS patients before pelvic radiotherapy, while in RIAIS patients relative to controls, trimethylamine, n-butyrate, fumarate and acetate were down-regulated and valine, TMAO, taurine, phenylalanine, lactate, isoleucine and creatinine were up-regulated. CONCLUSIONS: We obtained the metabolic profile of RIAIS patients from fecal samples using NMR-based metabonomics. This profile has the potential to be developed into a novel clinical tool for RIAIS diagnosis or therapeutic monitoring, and could contribute to an improved understanding of the disease mechanism. However, because of the limitations of methods, technique, bacterial contamination of feces and small sample size, further research and verification are needed.
OBJECTIVE: Radiation-induced acute intestinal symptoms (RIAISs) are a common complication of radiotherapy for cervical cancer. The aim of this study was to use (1)H nuclear magnetic resonance ((1)H NMR) combined with chemometric analysis to develop a metabolic profile of patients with RIAISs. METHODS: Fecal samples were collected from 66 patients with cervical cancer before and after pelvic radiotherapy. After radiotherapy, RIAISs occurred in eleven patients. We selected another 11 patients from participants without RIAISs whose age, stage, histological type and treatment methods are matched with RIAIS patients as the control group. (1)H NMR spectroscopy combined with multivariate pattern recognition analysis was used to generate metabolic profile data, as well as to establish a RIAIS-specific metabolic phenotype. RESULTS: Orthogonal partial least-squares discriminant analysis was used to distinguish samples between the pre- and post-radiotherapy RIAIS patients and between RIAIS patients and controls. Fecal samples from RIAIS patients after pelvic radiotherapy were characterized by increased concentrations of α-ketobutyrate, valine, uracil, tyrosine, trimethylamine N-oxide, phenylalanine, lysine, isoleucine, glutamine, creatinine, creatine, bile acids, aminohippurate, and alanine, accompanied by reduced concentrations of α-glucose, n-butyrate, methylamine, and ethanol relative to samples from RIAIS patients before pelvic radiotherapy, while in RIAIS patients relative to controls, trimethylamine, n-butyrate, fumarate and acetate were down-regulated and valine, TMAO, taurine, phenylalanine, lactate, isoleucine and creatinine were up-regulated. CONCLUSIONS: We obtained the metabolic profile of RIAIS patients from fecal samples using NMR-based metabonomics. This profile has the potential to be developed into a novel clinical tool for RIAIS diagnosis or therapeutic monitoring, and could contribute to an improved understanding of the disease mechanism. However, because of the limitations of methods, technique, bacterial contamination of feces and small sample size, further research and verification are needed.
Authors: Evan L Pannkuk; Evagelia C Laiakis; Jerry Angdisen; Meth M Jayatilake; Pelagie Ake; Lorreta Yun-Tien Lin; Heng-Hong Li; Albert J Fornace Journal: Radiat Res Date: 2022-06-01 Impact factor: 3.372
Authors: Catherine L J Brown; Hannah Scott; Crystal Mulik; Amy S Freund; Michael P Opyr; Gerlinde A S Metz; G Douglas Inglis; Tony Montina Journal: Metabolites Date: 2022-02-05
Authors: Miguel R Ferreira; Caroline J Sands; Jia V Li; Jervoise N Andreyev; Elena Chekmeneva; Sarah Gulliford; Julian Marchesi; Matthew R Lewis; David P Dearnaley Journal: Int J Radiat Oncol Biol Phys Date: 2021-08-02 Impact factor: 7.038